Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Prelude Therapeutics Inc shares valued at $6,044 were purchased by Vaddi Krishna on Dec 31 ’24. At $1.21 per share, Vaddi Krishna acquired 5,000 shares. The insider’s holdings grew to 142,553 shares worth approximately $0.16 million following the completion of this transaction.
Also, Vaddi Krishna purchased 10,000 shares, netting a total of over 12,000 in proceeds. Following the buying of shares at $1.20 each, the insider now holds 137,553 shares.
Before that, Combs Andrew had added 60,000 shares to its account. In a trade valued at $82,002, the Chief Chemistry Officer bought Prelude Therapeutics Inc shares for $1.37 each. Upon closing the transaction, the insider’s holdings increased to 60,000 shares, worth approximately $0.43 million.
As published in a research note from H.C. Wainwright on September 19, 2024, Prelude Therapeutics Inc [PRLD] has been rated up from a Neutral to a Buy and the price target has been revised to $5. Analysts at Barclays downgraded the stock from ‘”an Equal weight”‘ to ‘”an Underweight”‘ outlook in a report released in mid June. As of March 13, 2024, JMP Securities has initiated its “Mkt outperform” rating for PRLD. Earlier on February 20, 2024, H.C. Wainwright downgraded its rating. Their new recommendation was “a Neutral” for PRLD stock which previously was a “a Buy”.
Analyzing PRLD Stock Performance
During the last five days, there has been a drop of approximately -10.59%. Over the course of the year, Prelude Therapeutics Inc shares have dropped approximately -10.59%. Shares of the company reached a 52-week high of $1.4300 on 01/06/25 and a 52-week low of $1.1300 on 01/08/25. A 50-day SMA is recorded $1.1121, while a 200-day SMA reached $3.3137. Nevertheless, trading volume fell to 0.24 million shares from 0.28 million shares the previous day.
Support And Resistance Levels for Prelude Therapeutics Inc (PRLD)
According to the 24-hour chart, there is a support level at 1.0940, which, if violated, would cause prices to drop to 1.0479. In the upper region, resistance lies at 1.2221. The next price resistance is at 1.3041. RSI (Relative Strength Index) is 48.29 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.0074, which suggests the price will decrease in the coming days. Percent R is at 60.81%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
